期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
SARS-CoV-2 and bioimmunotherapy for ulcerative colitis
1
作者 KANG Yin-nan JIE You-cheng +4 位作者 LIU Shan-shan WANG Jun-ke LI Chu-yi YU Xiao-hui ZHANG Jiu-cong 《Journal of Hainan Medical University》 2022年第16期1-5,共5页
Novel coronavirus(SARS‑CoV‑2,SARS‑CoV‑2 for short)infection can cause a series of gastrointestinal damage.Related studies have reported that SARS‑CoV‑2 infection can lead to the occurrence and progression of ulcerativ... Novel coronavirus(SARS‑CoV‑2,SARS‑CoV‑2 for short)infection can cause a series of gastrointestinal damage.Related studies have reported that SARS‑CoV‑2 infection can lead to the occurrence and progression of ulcerative colitis,which may be related to the cytokine storm caused by SARS‑CoV‑2 infection.Recently,we have also paid attention to whether infection with SARS‑CoV‑2 will aggravate the condition of UC patients receiving biological immunotherapy and whether vaccination with SARS‑CoV‑2 is safe and effective for these patients.At present,the interaction mechanism between SARS‑CoV‑2,SARS‑CoV‑2 vaccine and ulcerative colitis is not fully understood,and more research is needed to further clarify the relationship. 展开更多
关键词 SARS‑CoV‑2 Ulcerative colitis BIOLOGICS IMMUNOSUPPRESSANTS SARS‑CoV‑2 vaccine Therapy Progress
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部